Thursday, May 19, 2016 1:25:15 AM
First, what difference (as to whether “NW has never made a mistake”) does it make with regard to his $180 million NWBO investment ($30 million AFTER the screening halt, mind you)? Are you implying that if NW was ever wrong in the past, he must be wrong now or could never be right?
Second, I take issue with your suggestion NW and his investment team are equivalent to mb posters. NW, managed the Invesco Perpetual High Income fund for approx 25 years and achieved an annual year-on-year return of more than 13%. NW Has 25 years of stellar returns; 25 years of developing and honing his investment methodology, investigatory processes and industry contacts and billions of dollars and influence to boot. NW ain’t your average MB investor.
Third, my point in discussing NW’s investment was not to declare he could not be wrong or was always right. My purpose was merely to imply that given NW’s insight, experience, resources and 25-year stunningly-stellar track record, it is clear he learned something spectacularly positive to invest $180 million dollars (which was approx 50% of NWBO’s market cap but only 27% of outstanding shares). People like NW don’t give away money for free. They do their dd and, unlike us, they have the money, contacts and much more access, to perform their dd a whole lot better than mb investors.
The only definitive proof that NWBO’s products work is FDA approval. Of course I can’t show that and I never said definitively that NWBO’s products work. What I said was, “if DCVax-L or Direct works, Nwbo will get to the finish line” and “The results from the open (arm) trial is not speculation. The sickest of the sick benefited from DCVax-L. This doesn't mean NWBO will definitely win the fight for FDA approval. But to say they won't, given the evidence we have (even though it's limited), is clearly speculation.”
When you take into consideration, DCVax-L open arm trial info and Germany’s and England’s EA programs, I believe again, there is evidence (though limited) that DCVax is likely to be efficacious.
I did not say what you imply I said—that DCVAX works. Please read my comments above again and inform me of the “holes”.
I won’t argue with you on these points. NWBO does “seem” to be doing all of those things. I have no explanation for their silence except for (1) the pending lawsuits and (2) the blinded trials. But, even these explanations should not prevent Linda from advocating the company publicly with regard to it’s unblinded open arm trial. I’m not a lawyer but I would think it preferable to be sued five years from now—after approval—then to let the stock fall from $10 to .85! I can think of no excuse to justify their silence!
But, I am sure you understand that you and I do not have the insight or info that Linda does. Everything we “feel” or everything that “seems” wrong is merely speculation and as you said, “opinion”.
Hindsight is 20/20. We can’t go back. We can only learn from our “adventures” and apply what we learned in the future. My lesson from investing in NWBO is to not get too greedy. If my investment doubles, I'll take my original investment (and perhaps 10- 20 % profit) off the table. Stock prices seldom go straight up.
I’m sorry for your life’s savings. But, you are not a fool. You took a risk, a calculated risk. Sometimes it doesn’t pan out. But, it’s too early to say right now with NWBO. The prospect for NWBO’s science has NEVER changed! I am still hopeful and am not selling one damn share. In fact, I’m accumulating!
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM